ArticleJournal of animal science2026
Dietary soybean-derived trypsin inhibitor protein reduces nursery pig performance and may exacerbate F18 enterotoxigenic Escherichia coli disease.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- FUT1 genetic polymorphism influences susceptibility to F18 enterotoxigenic Escherichia coli infection in pigs.Journal of animal science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soybean-derived trypsin inhibitor proteins (TIU) impair amino acid bioavailability and increase exogenous and endogenous nitrogen flow to the hindgut, thereby attenuating pig growth performance. High-protein diets potentiate proteolytic fermentation-induced alterations to the gut microbiome, which may increase opportunistic enterotoxigenic Escherichia coli (ETEC) proliferation and exacerbate disease. We hypothesized that feeding high-TIU diets to nursery pigs would reduce growth rates and exacerbate F18 ETEC disease. Two hundred and eighty-eight (5.42 ± 0.93 kg BW; Camborough 1050 × 337, [PIC, Hendersonville, TN]) newly weaned pigs were evenly allotted across two control rooms (CON) and two challenge rooms (ETEC). Pigs were allotted based on sex and α-(1,2) fucosyltransferase (FUT1) genotype, with both factors evenly distributed across all pens. Pens were randomly assigned to corn-soy diets consisting of 1.1, 2.4, or 4.2 TIU/mg, creating six treatments: CON1.1, CON2.4, CON4.2, ETEC1.1, ETEC2.4, and ETEC4.2 (8 pens/treatment). On day 10 (day post-infection [dpi] 0), pigs in the ETEC rooms were orally inoculated with 5 mL of 3.8 × 109 cfu/mL of an F18 ETEC culture. Pooled pen feces were assessed for dry matter (DM) on dpi 0, 3, 5, 7, 9, 11, 14, and 21. Pen growth performance, medical treatments, and mortality were assessed prior to infection (dpi -10 to 0) and post infection (dpi 0 to 28). On dpi 5 and 12, one pig/pen was sacrificed to assess ileal mucosal attachment of F18 ETEC via in situ hybridization. Pen was the experimental unit and data were analyzed for the interactive and main effects of diet and challenge. Increasing dietary TIU to 4.2 TIU/mg led to a 13-16% decrease in ADG compared to the 1.1 TIU/mg diets, regardless of the challenge (P = 0.014). A diet × challenge interaction was observed regarding mortality, with ETEC2.4 showing a 20.8% mortality rate compared to 0% in CON2.4 (P = 0.001). Similarly, 22.9% of ETEC2.4 pigs required antibiotic treatment compared with 0% of CON2.4 pigs (P = 0.001). Fecal DM from dpi 0-21 showed no interaction, but ETEC pens had lower fecal DM compared to CON pens from dpi 3-11 (P < 0.0001). On dpi 5, ileal F18 attachment was increased in ETEC versus CON pigs (3.7 × 10-3 vs 0.1 × 10-3 F18 copies/μm2, P < 0.0001). By dpi 12, ileal F18 attachment did not differ between challenge groups (P > 0.05), suggesting disease resolution. In conclusion, diets at or greater than 2.4 TIU/mg decreased pig growth and reduced livability in ETEC-infected nursery pigs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.